2 terminated, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow olorinab: new trials by email Literature Review of olorinab trials Research Report on olorinab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome Olorinab, Placebo - Irritable Bowel Syndrome | Phase 1 | Terminated | Arena Pharmaceuticals | 1 | 2021-01-29 | 2021-05-17 |
| Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) Olorinab, Placebo - Irritable Bowel Syndrome | Phase 2 | Terminated | Arena Pharmaceuticals | 273 | 2019-07-24 | 2025-01-30 |
| Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain Olorinab - Crohn's Disease, Abdominal Pain | Phase 2 | Completed | Arena Pharmaceuticals | 14 | 2017-07-19 | 2021-11-02 |
Abdominal Pain (2) · Irritable Bowel Syndrome (2) · Crohn Disease (1)
United States (3)
Arena CT.gov Administrator (3)